General MedicineSchedule H1 Prescription Drug
Tusclav-375
Amoxicillin 250mg + Potassium Clavulanate 125mg
Statutory Prescription Notice (Schedule H / H1 Drug)
Schedule H1 Drug: Strictly for prescription use.
Product Overview
Intermediate strength co-amoxiclav formulation for targeted antibacterial treatment.
Technical & Regulatory Specifications
| Brand Name | Tusclav-375 |
|---|---|
| Generic / INN Name | Amoxicillin & Potassium Clavulanate Tablets IP |
| Active Composition | Amoxicillin 250mg + Potassium Clavulanate 125mg |
| Dosage Strength | 375mg |
| Dosage Form | Film-coated Tablets |
| Packaging Presentation | Alu-Alu Strip |
| Therapeutic Category | General Medicine |
| Drug Classification | Schedule H1 Prescription Drug |
| Marketed By | Habbatus Pharmaceuticals Pvt. Ltd. |
| Manufacturing Standard | Qualified Partner Facility (GMP Certified Facility) |
Professional Reference Notice
This product summary is prepared exclusively for the informational reference of registered medical practitioners, dental surgeons, and licensed pharmacists in India. Not for consumer self-medication.